Complications of intravenous transplantation of allogeneic tissue-derived mesenchymal stem cells in patients with ALS

Phase 1

• Conditions: G12.21; Amyotrophic lateral sclerosis.; Amyotrophic lateral sclerosis

• Registration Number: IRCT20080728001031N26
• Lead Sponsor: Royan Institute

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2021

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

Age: 18-65
Both gender
Duration of disease onset: 6 months
Both type of ALS: Limb onset & Bulbar onset
FVC =40%
ALS-FRS= 23
Under treatment with Rilozule

Exclusion Criteria

Neurological and psychiatric concomitant disease
Concomitant systemic disease
Treatment with corticosteroid ,Ig,immunosuppressive during 12 months
Familial ALS

Study & Design

• Study Type: interventional
• Study Design: Not specified